Rett Syndrome and the Impact of MeCP2 Associated Transcriptional Mechanisms on Neurotransmission

Lisa M Monteggia, Ege T Kavalali

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Subtle alterations in synaptic function contribute to the pathophysiology associated with several neuropsychiatric diseases. Modifications in synaptic vesicle trafficking can cause frequency-dependent changes in neurotransmission, alter information coding in neural circuits, and affect long-term plasticity. Rett syndrome, a neurodevelopmental disorder that arises from mutations in the methyl-CpG-binding protein-2 (MeCP2) gene, is a salient example for such a disease state in which synaptic transmission-in particular, spontaneous neurotransmission and short-term synaptic plasticity, have been altered. MeCP2 is widely believed to be a transcriptional repressor that silences methylated genes. Recent studies have identified synaptic deficits associated with the loss of MeCP2 in several brain regions, including the hippocampus. These findings suggest a synaptic basis for neurological symptoms associated with Rett syndrome and suggest an important role for transcriptional repression in the regulation of neurotransmission. These studies also highlight the importance of histone deacetylation and DNA methylation, two key epigenetic mechanisms in controlling synaptic function. These mechanisms are essential for chromatin remodeling in neurons as well as for repression of gene activation by MeCP2 and related methyl-binding proteins. Future work focusing on the regulation of DNA methylation and histone deacetylation by synaptic activity and how these epigenetic alterations affect neurotransmission will be critical to elucidate the mechanisms underlying Rett syndrome. In addition, this work will also help delineate a key pathway that regulates properties of neurotransmission in the central nervous system that may underlie additional neuropsychiatric disorders.

Original languageEnglish (US)
Pages (from-to)204-210
Number of pages7
JournalBiological Psychiatry
Volume65
Issue number3
DOIs
StatePublished - Feb 1 2009

Fingerprint

Methyl-CpG-Binding Protein 2
Rett Syndrome
Synaptic Transmission
DNA Methylation
Epigenomics
Histones
Neuronal Plasticity
Chromatin Assembly and Disassembly
Synaptic Vesicles
Transcriptional Activation
Genes
Hippocampus
Carrier Proteins
Central Nervous System
Neurons
Mutation
Brain

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Rett Syndrome and the Impact of MeCP2 Associated Transcriptional Mechanisms on Neurotransmission. / Monteggia, Lisa M; Kavalali, Ege T.

In: Biological Psychiatry, Vol. 65, No. 3, 01.02.2009, p. 204-210.

Research output: Contribution to journalArticle

Monteggia, Lisa M ; Kavalali, Ege T. / Rett Syndrome and the Impact of MeCP2 Associated Transcriptional Mechanisms on Neurotransmission. In: Biological Psychiatry. 2009 ; Vol. 65, No. 3. pp. 204-210.
@article{ed2366c9431f4f1a8047234f7c45a3d0,
title = "Rett Syndrome and the Impact of MeCP2 Associated Transcriptional Mechanisms on Neurotransmission",
abstract = "Subtle alterations in synaptic function contribute to the pathophysiology associated with several neuropsychiatric diseases. Modifications in synaptic vesicle trafficking can cause frequency-dependent changes in neurotransmission, alter information coding in neural circuits, and affect long-term plasticity. Rett syndrome, a neurodevelopmental disorder that arises from mutations in the methyl-CpG-binding protein-2 (MeCP2) gene, is a salient example for such a disease state in which synaptic transmission-in particular, spontaneous neurotransmission and short-term synaptic plasticity, have been altered. MeCP2 is widely believed to be a transcriptional repressor that silences methylated genes. Recent studies have identified synaptic deficits associated with the loss of MeCP2 in several brain regions, including the hippocampus. These findings suggest a synaptic basis for neurological symptoms associated with Rett syndrome and suggest an important role for transcriptional repression in the regulation of neurotransmission. These studies also highlight the importance of histone deacetylation and DNA methylation, two key epigenetic mechanisms in controlling synaptic function. These mechanisms are essential for chromatin remodeling in neurons as well as for repression of gene activation by MeCP2 and related methyl-binding proteins. Future work focusing on the regulation of DNA methylation and histone deacetylation by synaptic activity and how these epigenetic alterations affect neurotransmission will be critical to elucidate the mechanisms underlying Rett syndrome. In addition, this work will also help delineate a key pathway that regulates properties of neurotransmission in the central nervous system that may underlie additional neuropsychiatric disorders.",
author = "Monteggia, {Lisa M} and Kavalali, {Ege T}",
year = "2009",
month = "2",
day = "1",
doi = "10.1016/j.biopsych.2008.10.036",
language = "English (US)",
volume = "65",
pages = "204--210",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Rett Syndrome and the Impact of MeCP2 Associated Transcriptional Mechanisms on Neurotransmission

AU - Monteggia, Lisa M

AU - Kavalali, Ege T

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Subtle alterations in synaptic function contribute to the pathophysiology associated with several neuropsychiatric diseases. Modifications in synaptic vesicle trafficking can cause frequency-dependent changes in neurotransmission, alter information coding in neural circuits, and affect long-term plasticity. Rett syndrome, a neurodevelopmental disorder that arises from mutations in the methyl-CpG-binding protein-2 (MeCP2) gene, is a salient example for such a disease state in which synaptic transmission-in particular, spontaneous neurotransmission and short-term synaptic plasticity, have been altered. MeCP2 is widely believed to be a transcriptional repressor that silences methylated genes. Recent studies have identified synaptic deficits associated with the loss of MeCP2 in several brain regions, including the hippocampus. These findings suggest a synaptic basis for neurological symptoms associated with Rett syndrome and suggest an important role for transcriptional repression in the regulation of neurotransmission. These studies also highlight the importance of histone deacetylation and DNA methylation, two key epigenetic mechanisms in controlling synaptic function. These mechanisms are essential for chromatin remodeling in neurons as well as for repression of gene activation by MeCP2 and related methyl-binding proteins. Future work focusing on the regulation of DNA methylation and histone deacetylation by synaptic activity and how these epigenetic alterations affect neurotransmission will be critical to elucidate the mechanisms underlying Rett syndrome. In addition, this work will also help delineate a key pathway that regulates properties of neurotransmission in the central nervous system that may underlie additional neuropsychiatric disorders.

AB - Subtle alterations in synaptic function contribute to the pathophysiology associated with several neuropsychiatric diseases. Modifications in synaptic vesicle trafficking can cause frequency-dependent changes in neurotransmission, alter information coding in neural circuits, and affect long-term plasticity. Rett syndrome, a neurodevelopmental disorder that arises from mutations in the methyl-CpG-binding protein-2 (MeCP2) gene, is a salient example for such a disease state in which synaptic transmission-in particular, spontaneous neurotransmission and short-term synaptic plasticity, have been altered. MeCP2 is widely believed to be a transcriptional repressor that silences methylated genes. Recent studies have identified synaptic deficits associated with the loss of MeCP2 in several brain regions, including the hippocampus. These findings suggest a synaptic basis for neurological symptoms associated with Rett syndrome and suggest an important role for transcriptional repression in the regulation of neurotransmission. These studies also highlight the importance of histone deacetylation and DNA methylation, two key epigenetic mechanisms in controlling synaptic function. These mechanisms are essential for chromatin remodeling in neurons as well as for repression of gene activation by MeCP2 and related methyl-binding proteins. Future work focusing on the regulation of DNA methylation and histone deacetylation by synaptic activity and how these epigenetic alterations affect neurotransmission will be critical to elucidate the mechanisms underlying Rett syndrome. In addition, this work will also help delineate a key pathway that regulates properties of neurotransmission in the central nervous system that may underlie additional neuropsychiatric disorders.

UR - http://www.scopus.com/inward/record.url?scp=58149280236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149280236&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2008.10.036

DO - 10.1016/j.biopsych.2008.10.036

M3 - Article

C2 - 19058783

AN - SCOPUS:58149280236

VL - 65

SP - 204

EP - 210

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 3

ER -